iRegene Therapeutics Secures Series B+ Financing Following FDA Fast Track Designation for its Flagship Product NouvNeu001
CHENGDU, China, Sept. 9, 2025 /PRNewswire/ -- iRegene Therapeutics (Chengdu) Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, announced on September 4th the successful completion of its Series B+ financing round, co-led by Northern Light Venture Capital, Chuangjing Capital, and OneHealth Haihe Capital, along with participation from other investors. In August 2025, NouvNeu001 received Fast...
Metabolon Partners with China Kadoorie Biobank to Advance Precision Health
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common diseases MORRISVILLE, N.C., Sept. 9, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine...
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine’s Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals
SHENZHEN, China, Sept. 9, 2025 /PRNewswire/ -- XtalPi Inc. (Stock Code: 2228.HK) has announced that PEP08, a next-generation PRMT5 inhibitor candidate developed through its AI drug discovery collaboration with PharmaEngine, Inc. (TWO:4162), has received regulatory clearances to initiate Phase 1 clinical trials in solid tumors. Approvals include Australia's Human Research Ethics Committee...
BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products
XI'AN, China, Sept. 9, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced it has entered into a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan") a prominent health products distributor in China. The term of the agreement...
RingConn Showcases Blood Pressure Insights Demo at IFA 2025
BERLIN, Sept. 9, 2025 /PRNewswire/ -- RingConn, the leading smart ring brand, announced its participation in the 2025 IFA Berlin, where it unveiled a demo of its upcoming Blood Pressure Insights feature. This marks the first public showcase of the technology and a major step forward in RingConn's mission to empower people with comprehensive, science-driven health management tools. ...
Infinitus’ “Better Health for 10,000 Households” Initiative Named Among China’s “Four 100s” Top Volunteer Service Projects
Strengthening Community Wellness and Supporting the Healthy China Initiative GUANGZHOU, China, Sept. 9, 2025 /PRNewswire/ -- A nationwide, government-led panel—organized by the Social Work Department of the CPC Central Committee in collaboration with 21 other agencies—has released the 2024 "Four 100s" list recognizing exemplary volunteer service efforts. "Better Health for 10,000 Households" initiated in Guangdong by Infinitus (China) Company Ltd....
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry
End-to-end Green CRDMO solutions to enable global clients for broader positive impact Span from biologics research, development, manufacturing, and overall operations Integration with lean management and digitalization for continuous excellence A comprehensive ecosystem featuring diverse energy-saving and carbon-reduction initiatives SHANGHAI, Sept. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO),...
Dizal Showcases Robust Portfolio of Lung Cancer Studies at 2025 WCLC
SHANGHAI, Sept. 9, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced the presentation of new findings on its leading assets, ZEGFROVY® (sunvozertinib) and golidocitinib, in non-small cell lung cancer (NSCLC) at the 2025 World Conference on Lung Cancer...
World-Renowned Artist Liu Bolin Unveils Three Singapore Works in Support of Persons living with Rare Disorders
Canvas of Hope is slated to launch this weekend with new artworks exploring visibility and advocacy; The Rare Gallery opens 14 September 2025 with charity art gala dinner set for 28 March 2026 SINGAPORE, Sept. 9, 2025 /PRNewswire/ -- Internationally acclaimed Chinese contemporary artist Liu Bolin, widely known as the "Invisible Man" for his thought-provoking camouflage performances, has unveiled three...
Bayer Foundation Backs 15 Women Entrepreneurs Scaling Urgent Healthcare and Food Solutions
LEVERKUSEN, Germany, Sept. 9, 2025 /PRNewswire/ -- The Bayer Foundation Women Entrepreneurs Award (BFWEA), powered by the Impact Hub Network, honours 15 women from Latin America, Africa & the Middle East, and Asia Pacific who are addressing critical challenges in healthcare and food security. Winners of the 2025 Bayer Foundation Women Entrepreneurs Awards According to reports by...
